Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms: QR1, NMORI, NMOR1, DTD, DIA4, DHQU
Anti-NQO1 Monoclonal Antibody
(3N194)

| Description | Anti-NQO1 Monoclonal Antibody (3N194) is a Mouse antibody targeting NQO1. Anti-NQO1 Monoclonal Antibody (3N194) can be used in WB,IHC,FCM. |
| Synonyms | QR1, NMORI, NMOR1, DTD, DIA4, DHQU |
| Ig Type | IgG1 |
| Clone | 3N194 |
| Reactivity | Human |
| Application | |
| Recommended Dose | WB: 1/500-1/2000; IHC: 1/200-1/1000; FCM: 1/200-1/400 |
| Antibody Type | Monoclonal |
| Host Species | Mouse |
| Construction | Hybridoma Monoclonal Antibody |
| Purification | Purified by protein A or protein G |
| Appearance | Liquid |
| Formulation | PBS with 0.05% sodium azide. |
| Concentration | 1 mg/mL |
| Research Background | This gene is a member of the NAD(P)H dehydrogenase (quinone) family and encodes a cytoplasmic 2-electron reductase. This FAD-binding protein forms homodimers and reduces quinones to hydroquinones. This protein's enzymatic activity prevents the one electron reduction of quinones that results in the production of radical species. Mutations in this gene have been associated with tardive dyskinesia (TD), an increased risk of hematotoxicity after exposure to benzene, and susceptibility to various forms of cancer. Altered expression of this protein has been seen in many tumors and is also associated with Alzheimer's disease (AD). Alternate transcriptional splice variants, encoding different isoforms, have been characterized. |
| Conjucates | Unconjugated |
| Immunogen | Purified recombinant fragment of human NQO1 expressed in E. Coli. |
| Antigen Species | Human |
| Gene Name | NQO1 |
| Gene ID | |
| Protein Name | NAD(P)H dehydrogenase [quinone] 1 |
| Uniprot ID |
| Molecular Weight | Theoretical: 31 kDa. |
| Stability & Storage | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| Transport | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.